Vedolizumab as the first line of biologic therapy for ulcerative colitis and Crohn's disease – a systematic review with meta-analysis
- Resource Type
- Review Article
- Source
- In
Digestive and Liver Disease September 2022 54(9):1168-1178 - Subject
- Language
- ISSN
- 1590-8658